VERTEX PHARMACEUTICALS, INC.

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 10, 2005

Accession Number

0001162663-05-000050

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →